Best Biopharma Outsourcing Companies in Tokyo, Japan
The 52 best Biopharma Outsourcing companies in Tokyo, Japan in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Sanamedi.
Our analysis of 100 Biopharma Outsourcing companies
$10.3b in tracked funding; 68% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Biopharma Outsourcing companies in Tokyo
| # | Company | Disclosed funding | Employees | Last round | Founder | Tech stack | Web popularity | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | m3 M3 provides healthcare professionals to improve the efficiency of the medical field. | — | 12,018 | — | — | — | — | — | — |
| 2 | H.U. Group Holdings Provider of clinical testing, diagnostics, and healthcare services. | — | 11,561 | — | — | Apple iCloud MailMicrosoft 365Apache HTTP Server+12 | Top 5M | — | — |
| 3 | toho holdings Toho Holdings focuses on pharmaceutical wholesale business, dispensing pharmacy business, and pharmaceutical… | — | 10,023 | — | Norio Hamada CEO & Director | Facebook LoginAmazon Web ServicesCloudflare+11 | Top 5M | — | — |
| 4 | Takeda Large diversified pharma company | — | 6,638 | 92 mo ago | Christophe Weber CEO | Optimizely Content ManagementTurbopackNode.js+24 | Top 500k | 57 patents Therapeutic biologics: fusion protein engineering, GM‑CSF neutralizing antibodies, and bacteriophage therapeutics. | — |
| 5 | EPS Corporation Provider of full solutions for pharmaceutical, medical device, and regenerative medicine | — | 6,220 | — | Takashi Tanaka President & CEO | Apple iCloud MailMicrosoft 365Nginx+11 | Top 5M | — | — |
| 6 | Nissan Chemical Manufacturer of APIs, pharmaceuticals, and industrial & agriculture chemicals | — | 3,317 | — | — | SalesforceYouTubeApache HTTP Server+4 | Top 5M | 14,158 patents Advanced semiconductor materials, photoresist/coating films, conductive inks, and graphene sensor devices | — |
| 7 | Mochida Pharmaceutical Provider of vehicle service contract marketing programs for dealerships | — | 2,044 | — | Naoyuki Mochida CEO | Red HatBackbone.jsApache HTTP Server+14 | Top 1M | 21 patents Patents concentrated in chemistry & materials | — |
| 8 | A2 Healthcare Full-service CRO based out of Japan | — | 1,155 | — | — | WordPressMySQLPHP+11 | Top 5M | 44 patents Synthesis of PET radiotracer flutemetamol and benzimidazole drugs for acid reflux treatment | — |
Top 12 Biopharma Outsourcing companies in Tokyo
#1
Series A · Chiyoda City, Tokyo · founded 2022$3.1Mraised▾
Provider of ferroptosis drug discovery and development solutions. It is a developer of therapeutic drugs to treat cancer and other diseases.
- Sep 2025Series A$3.1M
- Jun 2023Seed—
#2
Seed · Tokyo, Tokyo · founded 2022 · 7 employees$871.2Kraised▾
Provider of pharmaceuticals development & commercialization services
- Jan 2026Seed$569.7K
- Feb 2024Seed$871.2K
#3
Seed · Koto City, Tokyo · founded 2018 · 12 employees$1.6Mraised▾
Provider of Vivo reactions on protein arrays intended to deliver innovative research approach. The company performs high-precision immune profiling based on the resources and developed technologies established by the national institute of advanced industrial science and technology. enabling researchers to study drug discovery, regenerative medicine, and diagnosis.
- Sep 2025Seed$268.9K
- Jun 2022Seed$1.3M
#4
Series A · Chuo City, Tokyo · founded 2021 · 23 employees$1.7Mraised▾
Provider of AI development services for biopharma sector
- May 2025Series A$1.4M
- Aug 2024Series A$1.7M
#5
Series A · Chuo City, Tokyo · founded 2018 · 10 employees$7.5Mraised▾
Provides drug discovery using cell-free membrane protein preparation and unnatural amino acid
- Aug 2024Series A$4.8M
- Aug 2021Seed$2.7M
#6
Series A · Katsushika City, Tokyo · founded 2018 · 4 employees$4.6Mraised▾
Developer of phenotypic regenerative medicine platforms designed to overcome intractable diseases by manipulating cells with information. The company's platform performs accurate all-gene expression analysis technology to acquire the state of cells treated with various types of drugs and media as large-scale data to extract information, enabling pharmaceutical companies and research institutes to improve the quality of medicine cells at the whole gene level.
- Jul 2023Series A—
- Mar 2021Series A$4.6M
#7
Series B · Chuo, Tokyo · founded 2012$10Mraised▾
Provider of pharmaceutical quality assurance consulting services
- Feb 2016Series B$10M
#8
Seed · Koto City, Tokyo · founded 2021$1.7Mraised▾
Developer of drug discovery platform intended for drug target molecules and create breakthrough new drug candidate substances. The company offers a plom-con analysis method and semi-intact cell reseal technology, enabling reproduces the onset/progression of pathological cells and analyzing the protein network of the cells over time and comprehensively based on cell-stained image big data.
- Aug 2022Seed$1.7M
#9
Series A · Bunkyo, Tokyo · founded 2019 · 7 employees$2.8Mraised▾
Operator of a biotechnology platform engaged in drug discovery business utilizing structural analysis using a cryo-electron microscope. The company's product specializes in structural analysis technology that allows observation by freezing the in-vivo structure without staining, enabling researchers to discover and analyze life-saving drugs using structural analysis-based drug discovery methods.
- Jun 2021Series A$2.8M
#10
Series A · Shibuya, Tokyo · founded 2017—raised▾
Provider of diversified consulting services for biopharma sector
- Apr 2026Series A—
#11
Seed · Chuo City, Tokyo · founded 2018 · 7 employees—raised▾
Developer of a single-programmed medical device designed to treat lifestyle-related diseases. The company's device utilizes scientifically based digital therapy, enabling users to reduce the burden on medical staff and contribute to the optimization of medical costs in society.
- Jul 2024Seed—
#12
Seed · Shinagawa, Tokyo · founded 2023 · 2 employees—raised▾
Provider of pharmaceutical supply chain solutions. It helps to maximize the value of the company products through market research for medical products.
- Feb 2024Seed—
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Biopharma Outsourcing coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology in Tokyo is moving
A read on the academic research around Biotechnology in Tokyo — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 153 papers.
Tokyo's University of Tokyo and peers optimistically research RNA interference, gene delivery, and viral gene therapy, with breakthroughs dominating and minimal concern across 153 papers.
- The University of Tokyo76
- Tokyo University of Agriculture and Technology18
- Tokyo University of Science17
- Tokyo Medical and Dental University10
- Tokyo University of Agriculture8
- Gene2→8
- DNA methylation1→3
- Gene5
- Cell culture4
- Gene expression4
- Flow cytometry4
- Gene knockdown3
- Gene2
- Synthetic lethality1
- Olaparib1
- PARP inhibitor1
- Poly ADP ribose polymerase1
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.